BackRaphael Pharmaceutical Overview

Raphael Pharmaceutical Total Liabilities

Latest total liabilities for RAPH: $1.9M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$1.89M
↑ 75.51% YoYΔ $814000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Raphael Pharmaceutical Total Liabilities History

Loading

Raphael Pharmaceutical vs. peers: Total Liabilities Comparison

Loading

Raphael Pharmaceutical Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Raphael Pharmaceutical (RAPH) FAQ

The latest total liabilities for RAPH is $1.9M as of June 2026. That compares with $1.1M in the prior-year period — up 75.5% year over year. Investors often review this figure alongside Raphael Pharmaceutical's historical trend and sector peers before judging valuation or financial health.

Over the past year, RAPH's total liabilities moved from $1.1M to $1.9M — a 75.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Raphael Pharmaceutical's operating scale or balance-sheet position.

A total liabilities figure of $1.9M for RAPH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RAPH's total liabilities ($1.9M), review year-over-year change from $1.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.